Faris Alrumaihi

2.5k total citations · 2 hit papers
97 papers, 1.8k citations indexed

About

Faris Alrumaihi is a scholar working on Molecular Biology, Oncology and Plant Science. According to data from OpenAlex, Faris Alrumaihi has authored 97 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 14 papers in Oncology and 13 papers in Plant Science. Recurrent topics in Faris Alrumaihi's work include vaccines and immunoinformatics approaches (10 papers), Computational Drug Discovery Methods (9 papers) and Garlic and Onion Studies (7 papers). Faris Alrumaihi is often cited by papers focused on vaccines and immunoinformatics approaches (10 papers), Computational Drug Discovery Methods (9 papers) and Garlic and Onion Studies (7 papers). Faris Alrumaihi collaborates with scholars based in Saudi Arabia, Pakistan and India. Faris Alrumaihi's co-authors include Ahmad Almatroudi, Khaled S. Allemailem, Arshad Husain Rahmani, Mohammed A. Alsahli, Amjad Ali Khan, Saleh A. Almatroodi, Arif Khan, Shehwaz Anwar, Masood Alam Khan and Muhammad Tahir ul Qamar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Faris Alrumaihi

90 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management

2024 79 citations Shehwaz Anwar, Faris Alrumaihi et al. Biomolecules profile →
Pharmacological Potential of Kaempferol, a Flavonoid in the Management of Pathogenesis via Modulation of Inflammation and Other Biological Activities

2024 56 citations Faris Alrumaihi, Saleh A. Almatroodi et al. Molecules profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Faris Alrumaihi Saudi Arabia	26	733	226	189	185	179	97	1.8k
Xiaoqiang Huang China	26	1.2k 1.6×	326 1.4×	166 0.9×	216 1.2×	108 0.6×	98	2.5k
Sherif T. S. Hassan Czechia	27	770 1.1×	301 1.3×	152 0.8×	296 1.6×	259 1.4×	51	2.1k
Mаhmoud Youns Egypt	27	1.0k 1.4×	328 1.5×	195 1.0×	173 0.9×	65 0.4×	49	2.3k
Vikash Kumar India	23	789 1.1×	223 1.0×	144 0.8×	112 0.6×	177 1.0×	86	1.9k
Aleksandra Niedzwiecki United States	24	769 1.0×	165 0.7×	226 1.2×	111 0.6×	142 0.8×	104	2.3k
Ashraf N. Abdalla Saudi Arabia	24	745 1.0×	311 1.4×	293 1.6×	116 0.6×	119 0.7×	142	2.0k
Junsoo Park South Korea	26	763 1.0×	121 0.5×	216 1.1×	158 0.9×	198 1.1×	83	1.8k
Lianxiang Luo China	27	1.3k 1.8×	117 0.5×	279 1.5×	175 0.9×	293 1.6×	138	2.5k
Sameh S. M. Soliman United Arab Emirates	26	580 0.8×	443 2.0×	137 0.7×	114 0.6×	93 0.5×	121	2.2k
Khalaf F. Alsharif Saudi Arabia	22	417 0.6×	140 0.6×	118 0.6×	103 0.6×	110 0.6×	138	1.5k

Countries citing papers authored by Faris Alrumaihi

Since Specialization

Citations

This map shows the geographic impact of Faris Alrumaihi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faris Alrumaihi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faris Alrumaihi more than expected).

Fields of papers citing papers by Faris Alrumaihi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Faris Alrumaihi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faris Alrumaihi. The network helps show where Faris Alrumaihi may publish in the future.

Co-authorship network of co-authors of Faris Alrumaihi

This figure shows the co-authorship network connecting the top 25 collaborators of Faris Alrumaihi. A scholar is included among the top collaborators of Faris Alrumaihi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Faris Alrumaihi. Faris Alrumaihi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alrumaihi, Faris, et al.. (2025). A Multidimensional Approach to Understanding Genetic Diversity, Risk Stratification, and Personalized Interventions in Pediatric Hypertrophic Cardiomyopathy. Current Problems in Cardiology. 50(6). 103040–103040.

Alrumaihi, Faris, et al.. (2025). Histone modifications as molecular drivers of cardiac aging: Metabolic alterations, epigenetic mechanisms, and emerging therapeutic strategies. Current Problems in Cardiology. 50(7). 103056–103056. 1 indexed citations

Allemailem, Khaled S., Faris Alrumaihi, & Ahmad Almatroudi. (2025). Immunoinformatics-based design of a next generation multi-epitope vaccine candidate against Shigella boydii using a hierarchical subtractive proteomics approach. Scientific Reports. 16(1). 3359–3359.

Alrumaihi, Faris, et al.. (2025). The dual functionality of EZH2 in cardiovascular disease: Bridging cancer biology and cardiac pathophysiology through epigenetic regulation, metabolic reprogramming, and novel therapeutic interventions. Current Problems in Cardiology. 50(9). 103104–103104.

Anwar, Shehwaz, Faris Alrumaihi, Tarique Sarwar, et al.. (2024). Exploring Therapeutic Potential of Catalase: Strategies in Disease Prevention and Management. Biomolecules. 14(6). 697–697. 79 indexed citations breakdown →

Alrumaihi, Faris. (2024). Exploring the Chemopreventive Potential of Artemisia annua Methanolic Extract in Colorectal Cancer Induced by Azoxymethane in Mice. Pharmaceuticals. 18(1). 34–34. 1 indexed citations

Rahmani, Arshad Husain, Ahmad Almatroudi, Khaled S. Allemailem, et al.. (2023). Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways. International Journal of Molecular Sciences. 24(11). 9665–9665. 29 indexed citations

Allemailem, Khaled S., Saleh A. Almatroodi, Ahmad Almatroudi, et al.. (2023). Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management. International Journal of Molecular Sciences. 24(8). 7052–7052. 25 indexed citations

Naeem, Muhammad Ahsan, Muhammad Farooq, Mohsin Khurshid, et al.. (2022). Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols. Molecules. 27(10). 3297–3297. 13 indexed citations

10.

Allemailem, Khaled S., Mohammed A. Alsahli, Ahmad Almatroudi, et al.. (2022). Current updates of CRISPR/Cas9‐mediated genome editing and targeting within tumor cells: an innovative strategy of cancer management. Cancer Communications. 42(12). 1257–1287. 48 indexed citations

11.

Khan, Arif, Mohammed A. Alsahli, Mohammad Abdullah Aljasir, et al.. (2022). Experimental and Theoretical Insights on Chemopreventive Effect of the Liposomal Thymoquinone Against Benzo[a]pyrene-Induced Lung Cancer in Swiss Albino Mice. SHILAP Revista de lepidopterología. 16 indexed citations

12.

Khan, Mir Azam, Mohammad Azam Ansari, Shahab Uddin, et al.. (2022). Prospective Role of Bioactive Molecules and Exosomes in the Therapeutic Potential of Camel Milk against Human Diseases: An Updated Perspective. Life. 12(7). 990–990. 6 indexed citations

13.

Hassan, Heba Ali, Iman A. M. Abdel-Rahman, Khaled S. Allemailem, et al.. (2022). Targeting Natural Plant Metabolites for Hunting SARS-CoV-2 Omicron BA.1 Variant Inhibitors: Extraction, Molecular Docking, Molecular Dynamics, and Physicochemical Properties Study. Current Issues in Molecular Biology. 44(10). 5028–5047. 1 indexed citations

14.

Gul, Saba, Sajjad Ahmad, Asad Ullah, et al.. (2022). Designing a Recombinant Vaccine against Providencia rettgeri Using Immunoinformatics Approach. Vaccines. 10(2). 189–189. 46 indexed citations

15.

Sagar, Vinay, Ravi Ranjan, Rahul Sharma, et al.. (2021). Genotype Variations and Association between PAI-1 Promoter Region (4G/5G and -844G/A) and Susceptibility to Acute Myocardial Infarction and Chronic Stable Angina. Cardiology Research and Practice. 2021. 1–9. 4 indexed citations

16.

Ibrahim, Mahmoud A. A., Alaa H. M. Abdelrahman, Othman R. Alzahrani, et al.. (2021). Non-β-Lactam Allosteric Inhibitors Target Methicillin-Resistant Staphylococcus aureus: An In Silico Drug Discovery Study. Antibiotics. 10(8). 934–934. 28 indexed citations

17.

Allemailem, Khaled S., et al.. (2021). Antimicrobial Effect of Different Types of Honey on Selected ATCC Bacterial Strains. Pharmacognosy Journal. 13(1). 217–225. 7 indexed citations

18.

Allemailem, Khaled S., Ahmad Almatroudi, Faris Alrumaihi, et al.. (2021). Novel Approaches of Dysregulating Lysosome Functions in Cancer Cells by Specific Drugs and Its Nanoformulations: A Smart Approach of Modern Therapeutics. International Journal of Nanomedicine. Volume 16. 5065–5098. 35 indexed citations

19.

Rehman, Abdur, Xiukang Wang, Sajjad Ahmad, et al.. (2021). In Silico Core Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against Streptococcus pyogenes. International Journal of Environmental Research and Public Health. 18(21). 11355–11355. 8 indexed citations

20.

Ibrahim, Mahmoud A. A., Alaa H. M. Abdelrahman, Mohamed A. M. Atia, et al.. (2021). Blue Biotechnology: Computational Screening of Sarcophyton Cembranoid Diterpenes for SARS-CoV-2 Main Protease Inhibition. Marine Drugs. 19(7). 391–391. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact